Instructions Altabor tablets 20 mg blister No. 20
Composition
active ingredient: 1 tablet contains altabor in terms of tannic acid and dry matter 20 mg;
excipients: sorbitol (E 420), citric acid monohydrate, pectin (citrus), apricot flavoring (flavoring preparations, flavoring substances, natural flavoring substances, maltodextrin, silicon dioxide), magnesium stearate, talc, sodium saccharin.
Dosage form
Pills.
Main physicochemical properties: oval tablets from light brown to dark brown with inclusions, with a biconvex surface, with an odor due to the presence of a flavoring.
Pharmacotherapeutic group
Antivirals for systemic use. Direct-acting antivirals. Other antivirals. ATX code J05A X.
Pharmacological properties
Pharmacodynamics
The active ingredient of Altabor tablets is a dry extract of the leaves of gray alder and sticky alder, which contains a mixture of ellagitannins of mono- and oligomeric origin based on phenolic acids (ellagic, gallic, dilactone valonic acid). These polyphenolic compounds have antiviral properties against influenza virus, vesicular stomatitis and herpes simplex. The mechanism of antiviral action of Altabor is to induce interferon synthesis, inhibit the activity of influenza virus neuraminidase, as well as virus-specific thymidine kinase of herpes virus, which leads to the termination of viral DNA synthesis. Additional pharmacological properties of Altabor are antibacterial action against gram-positive (Staphylococcus aureus, Bacillus subtilis) and gram-negative (Escherichia coli, Pseudomonas aeruginosa, Proteus mirabilis, Klebsiella) microorganisms. The pharmacological properties of the drug are due to antioxidant, anti-inflammatory, membrane-stabilizing and analgesic effects, which enhances the pharmacotherapeutic properties of the drug in the treatment of acute respiratory viral infections and influenza, which are often complicated by bacterial infection and accompanied by inflammation and pain.
Pharmacokinetics
Not studied.
Indication
Altabor is used for the prevention and treatment of influenza and acute respiratory viral infections.
Contraindication
The use of Altabor is contraindicated in cases of hypersensitivity to the components of the drug or tannin-containing drugs.
Interaction with other medicinal products and other types of interactions
Due to its polyphenolic base, altabor forms complexes with metal salts (such as aluminum, bismuth, iron), which leads to the loss of pharmacological activity of the drug.
Application features
The drug cannot be prescribed in combination with Almagel, bismuth preparations, iron and other drugs containing metal ions.
The drug contains sorbitol, so patients with rare hereditary fructose intolerance should not use it.
If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.
The drug contains sodium (sodium saccharin), which should be taken into account by patients on a controlled sodium diet.
Ability to influence reaction speed when driving vehicles or other mechanisms
Data is missing.
Use during pregnancy or breastfeeding
There is no clinical data on the efficacy and safety of the drug in pregnant women, therefore Altabor is contraindicated in this category of patients.
If it is necessary to use the drug in breastfeeding women, breastfeeding should be discontinued.
Method of administration and doses
For prophylaxis, Altabor should be taken 2 tablets 3 times a day. The drug should be slowly dissolved in the oral cavity. The duration of prophylaxis is 7 days.
For treatment, Altabor is used 2 tablets 4 times a day. The drug is slowly dissolved in the oral cavity. The duration of treatment is 7 days.
Children
There are no clinical data on the efficacy and safety of the drug in children, therefore Altabor should not be prescribed to children under 14 years of age.
Overdose
In case of hypersensitivity to the components of the drug, an overdose may cause skin allergic reactions.
Treatment. It is necessary to stop taking the drug. It is recommended to induce vomiting or perform gastric lavage. Symptomatic treatment is indicated.
Adverse reactions
When using Altabor, nausea, irritation of the soft palate, and allergic reactions, including rash, itching, skin hyperemia, and urticaria, may occur.
Expiration date
2 years.
Do not use the drug after the expiration date.
Storage conditions
In the original packaging at a temperature not exceeding 25 °C.
Keep out of reach of children.
Packaging
10 tablets in a blister, 2 blisters in a pack.
Vacation category
Without a prescription.
Producer
Public Joint Stock Company "Research and Production Center "Borshchagov Chemical and Pharmaceutical Plant".
Location of the manufacturer and its business address
Ukraine, 03134, Kyiv, Myru St., 17.
